Skip to content
Catalyst

bisphenol AWhat was measured

Measured, with no finding

443 endpoints

Show what was measuredHide what was measured
  • glucose and insulin tolerance tests

    modulates

    After 4 days of treatment with either E2 or BPA, these mice developed chronic hyperinsulinemia, and their glucose and insulin tolerance tests were altered

    PMID 16393666 · one of two readings recorded this

  • glycemia after a single 10 ug/kg dose of BPA or E2 in adult mice; plasma insulin; islet insulin content; glucose and insulin tolerance tests

    decreases, rapid decrease in glycemia

    Not recorded as a finding: the paper never states the instrument the node requires

    The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin.

    PMID 16393666 · one of two readings recorded this

  • glycemia after a single 10 ug/kg dose, plasma insulin, pancreatic beta-cell insulin content, and glucose and insulin tolerance tests in adult mice

    decreases, rapid decrease in glycemia correlating with a rise of plasma insulin

    Not recorded as a finding: this platform holds no node for the endpoint

    The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin.

    PMID 16393666 · one of two readings recorded this

  • glycemia

    decreases

    The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin

    PMID 16393666 · one of two readings recorded this

  • pancreatic beta-cell insulin content

    increases

    This effect is visible after 2 days of treatment and starting at doses as low as 10 microg/kg/day

    PMID 16393666 · one of two readings recorded this

  • plasma insulin (chronic hyperinsulinemia)

    increases

    After 4 days of treatment with either E2 or BPA, these mice developed chronic hyperinsulinemia, and their glucose and insulin tolerance tests were altered

    PMID 16393666 · one of two readings recorded this

  • plasma insulin

    increases

    The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin

    PMID 16393666 · one of two readings recorded this

  • DNA methylation patterns of multiple cell signaling genes

    modulates

    We found permanent alterations in the DNA methylation patterns of multiple cell signaling genes, suggesting an epigenetic basis for estrogen imprinting

    PMID 16740699 · one of two readings recorded this

  • PDE4D4 5'-flanking CpG island methylation and expression with aging, normal prostate

    decreases

    a specific methylation cluster was identified in the 5'-flanking CpG island that was gradually hypermethylated with aging in normal prostates, resulting in loss of gene expression

    PMID 16740699 · one of two readings recorded this

  • PDE4D4 gene methylation in prostate cancer cells

    decreases

    Cell line studies confirmed that site-specific methylation is involved in transcriptional silencing of the PDE4D4 gene and showed hypomethylation of this gene in prostate cancer cells

    PMID 16740699 · one of two readings recorded this

  • PDE4D4 methylation and expression

    increases

    Early and prolonged hypomethylation at this site following neonatal estradiol or bisphenol A exposure resulted in continued, elevated PDE4D4 expression

    PMID 16740699 · one of two readings recorded this

  • prostate susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis

    increases

    transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or estradiol increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis

    PMID 16740699 · one of two readings recorded this

  • activated ERK1/2 levels

    increases

    we obtained increased levels of activated ERK1/2 15 minutes after treatment with the ERα agonist PPT

    PMID 18446233 · one of two readings recorded this

  • E2 and BPA effects on islet insulin content with antiestrogen ICI182,780

    decreases

    Figures 4A and B show that ICI182,780 completely blocks both E2 and BPA effects in a dose dependent manner, indicating that estrogen receptors are involved

    PMID 18446233 · one of two readings recorded this

  • E2- and BPA-induced increase in islet insulin content

    decreases

    Exposure to E2 or BPA strongly increased insulin content in islets from wild-type mice, yet this effect was completely abolished in islets from ERαKO mice

    PMID 18446233 · one of two readings recorded this

  • E2- and BPA-induced increase in islet insulin content

    increases

    In contrast, a strong increase in insulin content was observed in E2 and BPA cultured islets from ERβKO mice

    PMID 18446233 · one of two readings recorded this

  • ERK1/2 phosphorylation fluorescence intensity versus 0 min

    increases, p = 0.01

    *p = 0.01 Student's t-test comparing with column at 0 min

    PMID 18446233 · one of two readings recorded this

  • glucose-induced insulin secretion

    increases

    islets incubated with 1 nM E2 for 48 hours secrete more insulin than those treated with vehicle

    PMID 18446233 · one of two readings recorded this

  • increase in islet insulin content by PPT, BPA and E2 with ERK1/2 inhibitor PD98059

    decreases

    the increase in insulin content by the three ERα ligands was completely abolished by the ERK1/2 blocker PD98059

    PMID 18446233 · one of two readings recorded this

  • increase in islet insulin content with c-Src inhibitor PP1

    decreases

    The c-Src inhibitor PP1 showed a tendency to also inhibit the effect of the ERα agonists in insulin content, although it is only statistically significant in the case of BPA

    PMID 18446233 · one of two readings recorded this

  • insulin content of isolated mouse islets of Langerhans, radioimmunoassay (Coat-a-Count), after 48 h culture with BPA or after 4 days of BPA injection

    increases

    Not recorded as a finding: this platform holds no node for the endpoint

    We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect.

    PMID 18446233 · one of two readings recorded this

  • insulin mRNA level

    increases

    insulin mRNA levels were induced 1.6 fold 6 hours after islets were exposed to 10nM E2

    PMID 18446233 · one of two readings recorded this

  • intracellular calcium dynamics in response to glucose

    no effect

    None of the parameters analyzed showed significant differences

    PMID 18446233 · one of two readings recorded this

  • islet area and BrdU incorporation

    no effect

    Islet area was unchanged in E2 vs. vehicle-treated islets and no increase on BrdU incorporation was observed

    PMID 18446233 · one of two readings recorded this

  • islet area

    no effect

    Islet size was similar between islets from wild type and KO mice (12426±510 µm2 for ERαWT and 12123±415 µm2 for ERαKO; 15720±612 µm2 for ERβWT and 15977±764 µm2 for ERβKO; at least 100 islets from at least 3 different mice)

    PMID 18446233 · one of two readings recorded this

  • islet area

    no effect

    Islet size was similar between islets from wild type and KO mice (12426±510 µm2 for ERαWT and 12123±415 µm2 for ERαKO; 15720±612 µm2 for ERβWT and 15977±764 µm2 for ERβKO; at least 100 islets from at least 3 different mice)

    PMID 18446233 · one of two readings recorded this

  • islet cell viability

    no effect

    The islet cell viability remained high and similar in both E2 and vehicle-treated islets

    PMID 18446233 · one of two readings recorded this

  • islet insulin content, dose response

    increases

    Insulin content increased following an inverted-U dose-dependent response at doses similar to the physiological concentrations of E2 observed in the mouse during pregnancy and in the proestrus stage

    PMID 18446233 · one of two readings recorded this

  • islet insulin content, dose response

    increases

    Figure 3A shows a BPA-induced increase of insulin content following an inverted U-shape dose response curve, with a significant effect observed at 1 nM and 10 nM BPA when compared to vehicle exposed islets

    PMID 18446233 · one of two readings recorded this

  • islet insulin content in vivo

    no effect

    We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect

    PMID 18446233 · one of two readings recorded this

  • islet insulin content in vivo

    increases

    We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect

    PMID 18446233 · one of two readings recorded this

  • islet insulin content

    no effect

    the ERβ agonist DPN produced no effect at any of the tested concentrations

    PMID 18446233 · one of two readings recorded this

  • islet insulin content

    increases

    The ERα agonist PPT had the same effect on insulin content as E2

    PMID 18446233 · one of two readings recorded this

  • islet insulin content

    no effect

    Higher concentrations of BPA as 1 µM produced no increase in insulin content

    PMID 18446233 · one of two readings recorded this

  • non-stimulated islet insulin content

    no effect

    The absence of ERα or ERβ did not affect the non-stimulated insulin content of cultured islets when compared to wild-type mice

    PMID 18446233 · one of two readings recorded this

  • pancreatic islet insulin content, radioimmunoassay (Coat-a-Count) after BPA in cultured mouse islets and in vivo

    increases

    Not recorded as a finding: this platform holds no node for the endpoint

    Therefore BPA, like E2, increases pancreatic insulin content in a non-monotonic manner.

    PMID 18446233 · one of two readings recorded this

  • FOS induction in GnRH neurons after hormone priming

    decreases

    FOS induction in hypothalamic gonadotropic (GnRH) neurons after hormone priming was impaired in the EB- and PPT-treated groups but neither of the BPA-treated groups

    PMID 19535786 · one of two readings recorded this

  • ovarian antral-like follicles and corpora lutea

    modulates

    Severity of deficits within the BPA-treated groups increased with dose and included large antral-like follicles and lower numbers of corpora lutea

    PMID 19535786 · one of two readings recorded this

  • ovarian morphology and folliculogenesis (EB)

    decreases

    Ovaries from the EB-treated females were undersized and showed no evidence of folliculogenesis

    PMID 19535786 · one of two readings recorded this

  • ovarian morphology (PPT)

    modulates

    ovaries from the PPT-treated females were characterized by large antral-like follicles, which did not appear to support ovulation

    PMID 19535786 · one of two readings recorded this

  • proportion of females acyclic

    increases

    A total of 67% of females exposed to the high BPA dose were acyclic by 15 wk after vaginal opening compared with 14% of those exposed to the low BPA dose

    PMID 19535786 · one of two readings recorded this

  • proportion of females acyclic

    increases

    A total of 67% of females exposed to the high BPA dose were acyclic by 15 wk after vaginal opening compared with 14% of those exposed to the low BPA dose

    PMID 19535786 · one of two readings recorded this

  • pubertal onset

    decreases

    Exposure to EB, PPT, or the low dose of BPA advanced pubertal onset

    PMID 19535786 · one of two readings recorded this

  • sexual receptivity after ovariectomy and hormone replacement

    no effect

    Sexual receptivity, examined after ovariectomy and hormone replacement, was normal in all groups except those neonatally exposed to EB

    PMID 19535786 · one of two readings recorded this

  • morphology of seminiferous cords, Sertoli cells, gonocytes, interstitial region and Leydig cells

    no effect

    Neither EE nor BPA exposure caused morphological changes in the developing seminiferous cords, Sertoli cells, gonocytes, or the interstitial region or Leydig cells at GD16-20

    PMID 22752971 · one of two readings recorded this

  • StAR protein, interstitial region

    no effect

    Immunohistochemistry demonstrated similar StAR protein levels in interstitial region of GD16 testes

    PMID 22752971 · one of two readings recorded this

  • StAR protein, interstitial region

    decreases

    an obvious decrease in StAR protein levels in the interstitial region of GD18 testes

    PMID 22752971 · one of two readings recorded this

  • StAR protein, interstitial region

    decreases

    immunohistochemistry results demonstrated decreases in StAR protein levels in the interstitial region at the highest EE and BPA doses only

    PMID 22752971 · one of two readings recorded this

  • StAR transcript levels

    no effect

    Quantitative reverse transcriptase PCR (QRT-PCR) demonstrated no significant difference in StAR transcript levels present at GD16

    PMID 22752971 · one of two readings recorded this

  • StAR transcript levels

    decreases

    at GD18, StAR transcripts were significantly decreased following exposure

    PMID 22752971 · one of two readings recorded this

  • StAR transcript levels

    decreases

    QRT-PCR validated previous microarray dose-related decreases in StAR transcripts at GD20

    PMID 22752971 · one of two readings recorded this

  • StAR transcript (QRT-PCR) and StAR protein (immunohistochemistry) in fetal rat testis after transplacental BPA or ethynyl estradiol

    decreases, decreased StAR protein in interstitial region at the highest EE and BPA doses only

    Not recorded as a finding: this platform holds no node for the endpoint

    QRT-PCR validated previous microarray dose-related decreases in StAR transcripts at GD20, whereas immunohistochemistry results demonstrated decreases in StAR protein levels in the interstitial region at the highest EE and BPA doses only.

    PMID 22752971 · one of two readings recorded this

  • 5-HIAA levels and 5-HIAA/5-HT

    increases

    BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice

    PMID 23567477 · one of two readings recorded this

  • 5-HIAA levels and 5-HIAA/5-HT

    unclear

    In contrast, alterations in those areas were much smaller in adult females and in both juvenile and adult males

    PMID 23567477 · one of two readings recorded this

  • contextual fear conditioning memory, brain regional serotonin metabolite 5-HIAA and 5-HIAA/5-HT by HPLC, and Tph2, Slc6a4 and Maoa mRNA by quantitative real-time RT-PCR in mice

    increases, enhanced fear memory and increased 5-HIAA levels in juvenile female mice

    Not recorded as a finding: this platform holds no node for the endpoint

    BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice.

    PMID 23567477 · one of two readings recorded this

  • contextual fear memory and brain regional 5-HIAA and 5-HIAA/5-HT by HPLC in mice after perinatal BPA 250 ng/kg/day

    increases, enhanced fear memory; increased 5-HIAA and 5-HIAA/5-HT in juvenile female brain regions

    Not recorded as a finding: this platform holds no node for the endpoint

    BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice.

    PMID 23567477 · one of two readings recorded this

  • contextual fear memory

    increases

    BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice

    PMID 23567477 · one of two readings recorded this

  • Tph2, Slc6a4 and Maoa mRNA expression

    increases

    BPA induced increases in the expression levels of Tph2, Slc6a4, and Maoa mRNA in the hippocampus of juvenile females

    PMID 23567477 · one of two readings recorded this

  • DNA methylation of the ERα gene

    modulates

    Importantly, changes in ERα and DNMT expression in the cortex (males) and hypothalamus (females) were associated with DNA methylation changes in the ERα gene

    PMID 23716699 · one of two readings recorded this

  • expression of estrogen receptor alpha, estrogen receptor beta and estrogen-related receptor-gamma genes

    modulates

    maternal exposure during pregnancy to environmentally relevant doses of BPA (2, 20, and 200 µg/kg/d) in mice induces sex-specific, dose-dependent (linear and curvilinear), and brain region-specific changes in expression of genes encoding estrogen receptors (ERs; ERα and ERβ) and estrogen-related receptor-γ in juvenile offspring

    PMID 23716699 · one of two readings recorded this

  • mRNA levels of DNMT1 and DNMT3A

    modulates

    Concomitantly, BPA altered mRNA levels of epigenetic regulators DNA methyltransferase (DNMT) 1 and DNMT3A in the juvenile cortex and hypothalamus, paralleling changes in estrogen-related receptors

    PMID 23716699 · one of two readings recorded this

  • postnatal maternal care

    modulates

    Although postnatal maternal care was altered in mothers treated with BPA during pregnancy, the effects of in utero BPA were not found to be mediated by maternal care

    PMID 23716699 · one of two readings recorded this

  • social and anxiety-like behavior

    modulates

    BPA exposure induced persistent, largely sex-specific effects on social and anxiety-like behavior, leading to disruption of sexually dimorphic behaviors

    PMID 23716699 · one of two readings recorded this

  • activity in open field test, sex difference

    modulates

    The OFT indicated that females were more active than males, and that BPA selectively increased rearing duration in males, thereby eliminating the gender effect

    PMID 23824010 · one of two readings recorded this

  • anxiety-like action

    decreases

    The results of EPM showed that BPA did not enhance the anxiety-like action; rather, it was associated with an anxiolytic-like action in females

    PMID 23824010 · one of two readings recorded this

  • immobility time and latency in the forced swimming test in rat offspring after lactational BPA; open field rearing; elevated plus maze

    increases, increase in immobility time and reduced latency in BPA rats

    Not recorded as a finding: this platform holds no node for the endpoint

    In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats.

    PMID 23824010 · one of two readings recorded this

  • immobility time

    increases

    In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats

    PMID 23824010 · one of two readings recorded this

  • latency

    decreases

    In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats

    PMID 23824010 · one of two readings recorded this

  • open field rearing duration, elevated plus maze anxiety-like behaviour, and forced swim test immobility time and latency in rat offspring exposed through lactation

    increases, increase in immobility time and reduced latency in BPA rats

    Not recorded as a finding: this platform holds no node for the endpoint

    In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats.

    PMID 23824010 · one of two readings recorded this

  • rearing duration

    increases

    BPA selectively increased rearing duration in males

    PMID 23824010 · one of two readings recorded this

  • serum adiponectin

    decreases

    Compared to negative controls, males in the BPA-5, BPA-50 and BPA-5000 groups had significantly lower serum adiponectin, with maximal reduction in the BPA-50 group

    PMID 23892310 · one of two readings recorded this

  • serum leptin

    increases

    The BPA-500 and the DES-0.1 groups had significantly elevated serum leptin levels compared to the negative controls and BPA-50,000 males

    PMID 23892310 · one of two readings recorded this

  • body weight, all groups pooled, birth to postnatal day 22

    increases

    body weight increased significantly from an average of 1.73 g on the day of birth to 13.6 g on postnatal day 22 (week 3)

    PMID 23892310 · one of two readings recorded this

  • body weight at weaning, quadratic vs linear model fit

    modulates, p = 0.016

    the quadratic model fit the data significantly better (P=0.016) than the linear-only model

    PMID 23892310 · one of two readings recorded this

  • body weight at weaning

    decreases

    At weaning the BPA-5000 group had significantly decreased body weight compared to negative controls and DES-0.1 males (Table 1)

    PMID 23892310 · one of two readings recorded this

  • body weight at week 19, quadratic vs linear model fit

    modulates, p = 0.034

    At week 19 (the end of the experiment) the regression analysis resulted in a significant difference between the groups as well as a better fit (P=0.034) relative to the linear-only model

    PMID 23892310 · one of two readings recorded this

  • body weight at week 19

    no effect, p = 0.07

    The BPA-500 males tended to be heavier than negative controls (P=0.07) and were significantly heavier than BPA-5000 males (Table 1)

    PMID 23892310 · one of two readings recorded this

  • body weight gain per week, weeks 15 to 19

    increases

    only the BPA-500 group showed a greater weight gain (2.82 ± 0.29 g) relative to negative controls (1.60 ± 0.18g) during this time

    PMID 23892310 · one of two readings recorded this

  • body weight on day of birth

    no effect, p = 0.08

    although the BPA-500 males tended (P=0.08) to be heavier than negative controls

    PMID 23892310 · one of two readings recorded this

  • glucose tolerance test AUC, linear ANOVA

    no effect, p = 0.06

    showed a tendency to be different (P = 0.06; Fig. 5A)

    PMID 23892310 · one of two readings recorded this

  • glucose tolerance test AUC, quadratic vs linear model fit

    modulates, p = 0.008

    Addition of the quadratic term fit the data significantly better than the linear-only model (P = 0.008)

    PMID 23892310 · one of two readings recorded this

  • glucose tolerance test AUC

    increases

    Compared to the negative controls, with the exception of the BPA-50,000 group, all other BPA dose groups as well as the DES-0.1 group showed significantly increased AUC values (impaired glucose tolerance)

    PMID 23892310 · one of two readings recorded this

  • gonadal adipocyte number

    increases

    The BPA-5 and BPA-500 males had significantly more adipocytes compared to negative controls, the BPA-50, and BPA-50,000 males

    PMID 23892310 · one of two readings recorded this

  • gonadal adipocyte number

    increases

    The DES-0.1 males also had significantly more adipocytes than negative controls, BPA-50 and BPA-50,000 males

    PMID 23892310 · one of two readings recorded this

  • gonadal adipocyte volume

    increases

    Although no group had significantly different adipocyte volume relative to negative controls, BPA-5 and BPA-500 males had significantly larger adipocytes relative to BPA-50, BPA-50,000 and DES-0.1 males

    PMID 23892310 · one of two readings recorded this

  • gonadal fat cell number

    modulates, p = 0.002

    The linear ANOVA for gonadal fat cell number was statistically significant (P<0.01), and addition of the quadratic term resulted in a significantly better fit than the linear-only model (P=0.002)

    PMID 23892310 · one of two readings recorded this

  • gonadal fat cell volume, quadratic vs linear model fit

    no effect, p = 0.052

    addition of the quadratic term tended to result in a better fit relative to the linear-only model (P=0.052)

    PMID 23892310 · one of two readings recorded this

  • gonadal fat pad weight, quadratic vs linear model fit

    modulates, p = 0.022

    addition of the quadratic term to the model provided a significantly better fit relative to the linear-only model (P=0.022; Table 2)

    PMID 23892310 · one of two readings recorded this

  • gonadal fat pad weight

    increases, p = 0.05

    gonadal fat pad weight was significantly greater in the BPA-500 group (P<0.05)

    PMID 23892310 · one of two readings recorded this

  • gonadal fat pad weight

    increases, p = 0.01

    the BPA-500 males also were significantly different compared to the BPA-50,000 group (P < 0.01; Fig. 2A)

    PMID 23892310 · one of two readings recorded this

  • insulin tolerance test AUC, quadratic vs linear model fit

    no effect, p = 0.137

    adding the quadratic term to the model did not result in a statistically significant difference (P = 0.137)

    PMID 23892310 · one of two readings recorded this

  • insulin tolerance test AUC

    increases

    the BPA-5 and BPA-5000 groups had significantly greater insulin insensitivity

    PMID 23892310 · one of two readings recorded this

  • insulin tolerance test AUC

    no effect, p = 0.07

    the DES-0.1 males tended to have greater insulin insensitivity (P = 0.07)

    PMID 23892310 · one of two readings recorded this

  • kidney weight

    no effect

    The linear ANOVA for kidney weight was not statistically significant, and addition of the quadratic term in the regression analysis also was also not statistically significant (data not shown)

    PMID 23892310 · one of two readings recorded this

  • liver steatosis

    no effect

    there was no significant relationship between prenatal treatment and steatosis (data not shown)

    PMID 23892310 · one of two readings recorded this

  • liver weight, quadratic vs linear model fit

    modulates, p = 0.001

    The linear ANOVA for liver weight was statistically significant (P = 0.01), and addition of the quadratic term in the regression analysis led to a significantly better fit compared to the linear-only model (P < 0.001)

    PMID 23892310 · one of two readings recorded this

  • liver weight

    increases, p = 0.01

    Compared to the negative controls, the BPA-50 group had significantly higher liver weight (P < 0.01)

    PMID 23892310 · one of two readings recorded this

  • metabolic energy intake, weeks 3 to 4, quadratic vs linear model fit

    modulates, p = 0.028

    between weeks 3 and 4 the quadratic model fit the data significantly better (P=0.028) than the linear-only model

    PMID 23892310 · one of two readings recorded this

  • metabolic energy intake, weeks 3 to 4

    increases, p = 0.05

    the DES-0.1-treated animals exhibited the largest increase in metabolic energy intake relative to negative controls (P < 0.05)

    PMID 23892310 · one of two readings recorded this

  • metabolic energy intake, weeks 4 to 5, quadratic vs linear model fit

    modulates, p = 0.025

    Between weeks 4 and 5 the quadratic model again fit the data better (P = 0.025) than the linear-only model

    PMID 23892310 · one of two readings recorded this

  • metabolic energy intake, weeks 4 to 5

    increases, p = 0.05

    only the BPA-500 males exhibited a significant increase in metabolic energy intake relative to negative controls (P < 0.05)

    PMID 23892310 · one of two readings recorded this

  • renal adipocyte number

    increases

    The BPA-500 males had significantly more adipocytes in the renal fat pad compared to the negative controls and all other BPA dose groups

    PMID 23892310 · one of two readings recorded this

  • renal adipocyte volume

    no effect, p = 0.06

    Compared to the negative controls, the BPA-5 (P=0.06) and BPA-5000 (P< 0.01) had larger renal adipocytes

    PMID 23892310 · one of two readings recorded this

  • renal adipocyte volume

    increases, p = 0.01

    Compared to the negative controls, the BPA-5 (P=0.06) and BPA-5000 (P< 0.01) had larger renal adipocytes

    PMID 23892310 · one of two readings recorded this

  • renal fat pad weight, quadratic vs linear model fit

    no effect, p = 0.076

    addition of the quadratic term to the model tended to result in a better fit relative to the linear-only model (P=0.076)

    PMID 23892310 · one of two readings recorded this

  • renal fat pad weight

    increases

    Compared to the negative controls and the BPA-50,000 groups, the BPA-500 group had elevated renal fat pad weight (P <0.05 and P <0.01, respectively)

    PMID 23892310 · one of two readings recorded this

  • renal fat pad weight

    no effect, p = 0.07

    The DES-0.1 males tended (P=0.07) to have heavier renal fat pads compared to negative controls

    PMID 23892310 · one of two readings recorded this

  • serum adiponectin, quadratic vs linear model fit

    no effect, p = 0.099

    addition of the quadratic term in the regression analysis tended to result in a better fit (P = 0.099) relative to the linear-only model

    PMID 23892310 · one of two readings recorded this

  • serum insulin in fed animals, radioimmunoassay

    increases, about 2-fold higher in the BPA-5 and DES-0.1 groups

    Not recorded as a finding: no insulin concentration outcome node (only stimulated postprandial insulin exists, which requires an amino-acid preload and mixed drink)

    The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups.

    PMID 23892310 · one of two readings recorded this

  • serum insulin, mouse radioimmunoassay (fed state)

    increases, about 2-fold higher in BPA-5 and DES-0.1 groups

    Not recorded as a finding: No serum insulin outcome node; also compares against a BPA dose group and DES

    The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups.

    PMID 23892310 · one of two readings recorded this

  • serum insulin, quadratic vs linear model fit

    modulates, p = 0.004

    addition of the quadratic term in the regression analysis resulted in a significantly better fit relative to the linear-only model (P = 0.004)

    PMID 23892310 · one of two readings recorded this

  • serum insulin

    increases

    The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups

    PMID 23892310 · one of two readings recorded this

  • serum leptin, mouse radioimmunoassay (fed state)

    increases, BPA-500 and DES-0.1 groups significantly elevated versus negative controls and BPA-50,000

    Not recorded as a finding: Significant only in the BPA-500 stratum and the sentence also compares against another BPA dose group (BPA-50,000) and a DES positive control; no clean BPA-versus-vehicle contrast quotable in one sentence

    The BPA-500 and the DES-0.1 groups had significantly elevated serum leptin levels compared to the negative controls and BPA-50,000 males.

    PMID 23892310 · one of two readings recorded this

  • serum leptin, quadratic vs linear model fit

    no effect, p = 0.349

    addition of the quadratic term did not result in a significantly different fit relative to the linear-only model (P = 0.349)

    PMID 23892310 · one of two readings recorded this

  • serum leptin versus total abdominal fat weight profile

    increases, p = 0.001

    The profile for the BPA dose effect on adult serum leptin matched the total abdominal fat weight profile (; Spearman correlation coefficient = 0.86; P < 0.001)

    PMID 23892310 · one of two readings recorded this

  • total abdominal fat weight, quadratic vs linear model fit

    modulates, p = 0.047

    inclusion of the quadratic term resulted in a significantly better fit than the linear-only model (P=0.047)

    PMID 23892310 · one of two readings recorded this

  • total abdominal fat weight

    increases

    Compared to the negative controls and the BPA-50,000 groups, the BPA-500 group had more total abdominal fat (P < 0.05 and P < 0.01, respectively)

    PMID 23892310 · one of two readings recorded this

  • total metabolic energy consumed, weeks 15 to 19

    modulates, p = 0.001

    prenatal treatment was significantly different based on linear ANOVA for the total amount metabolic energy consumed over this 4-week period (P < 0.001)

    PMID 23892310 · one of two readings recorded this

  • human oocyte meiotic maturation in vitro, percentage of germinal vesicle oocytes reaching metaphase II after 30 h culture with BPA at 20 and 200 ng/ml and 20 ug/ml versus sibling control without BPA; spindle configuration and chromosome alignment by immunofluorescence and confocal microscopy

    decreases, p = 0.002

    Not recorded as a finding: this platform holds no node for the endpoint

    As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007).

    PMID 23904465 · one of two readings recorded this

  • Incidence of aligned chromosomes among MII oocytes

    decreases, p = 0.02

    Among MII oocytes, as the BPA dose increased, there was a significant trend (by test for trend) for a decreased incidence of bipolar spindles (P < 0.0001) and aligned chromosomes (P = 0.02)

    PMID 23904465 · one of two readings recorded this

  • Incidence of bipolar spindles among MII oocytes

    decreases, p = 0.0001

    Among MII oocytes, as the BPA dose increased, there was a significant trend (by test for trend) for a decreased incidence of bipolar spindles (P < 0.0001) and aligned chromosomes (P = 0.02)

    PMID 23904465 · one of two readings recorded this

  • Percentage of degenerated oocytes

    increases, p = 0.01

    As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)

    PMID 23904465 · one of two readings recorded this

  • percentage of human GV-stage oocytes progressing to metaphase II after 30 h in vitro culture with BPA (20, 200 ng/ml, 20 ug/ml) versus sibling oocytes without BPA; also degeneration, spontaneous activation, bipolar spindle and chromosome alignment, by immunofluorescence and confocal microscopy

    decreases, dose-dependent decrease in the percentage of oocytes progressing to MII, p = 0.002

    Not recorded as a finding: this platform holds no node for the endpoint

    As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007).

    PMID 23904465 · one of two readings recorded this

  • Percentage of oocytes progressing to metaphase II (MII)

    decreases, p = 0.002

    As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)

    PMID 23904465 · one of two readings recorded this

  • Percentage of oocytes with spontaneous activation

    increases, p = 0.007

    As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)

    PMID 23904465 · one of two readings recorded this

  • neuronal differentiation after withdrawal

    decreases

    The inhibitory effects were still observed when PC12 cells were treated with BPA or NP for a week, followed by a week's withdrawal

    PMID 24746930 · one of two readings recorded this

  • neuronal differentiation of PC12 cells after pre-exposure to 0.1-100 nM BPA

    decreases, decreased after one week or one month pre-exposure, not after one day

    Not recorded as a finding: this platform holds no node for the endpoint

    Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells.

    PMID 24746930 · one of two readings recorded this

  • neuronal differentiation of pheochromocytoma PC12 cells after pre-exposure to 0.1-100 nM BPA

    decreases

    Not recorded as a finding: this platform holds no node for the endpoint

    Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells.

    PMID 24746930 · one of two readings recorded this

  • neuronal differentiation

    no effect

    Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells

    PMID 24746930 · one of two readings recorded this

  • neuronal differentiation

    decreases

    Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells

    PMID 24746930 · one of two readings recorded this

  • neuronal differentiation

    decreases

    Likewise, one week's pre-exposure to NP also inhibited neuronal differentiation in these cells

    PMID 24746930 · one of two readings recorded this

  • hippocampal synaptic structure (synaptic cleft, PSD thickness, synaptic vesicles)

    modulates

    Maternal BPA exposure had an adverse effect on synaptic structure, including a widened synaptic cleft, a thinned postsynaptic density (PSD), unclear synaptic surface and disappeared synaptic vesicles

    PMID 24820113 · one of two readings recorded this

  • locomotor activity, exploratory habits and emotional behavior

    modulates

    Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test

    PMID 24820113 · one of two readings recorded this

  • reference and working memory errors in the radial arm maze, open field behavior, hippocampal synaptic ultrastructure and synaptic protein expression in male rat offspring after maternal BPA

    increases, increased reference and especially working memory errors

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test, and increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage.

    PMID 24820113 · one of two readings recorded this

  • reference and working memory errors in the radial arm maze, open field behaviour, hippocampal synaptic ultrastructure and synaptic protein mRNA and protein expression in male rat offspring at PND 21

    increases, increased reference and especially working memory errors in the radial arm maze

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test, and increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage.

    PMID 24820113 · one of two readings recorded this

  • reference and working memory errors

    increases

    increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage

    PMID 24820113 · one of two readings recorded this

  • synaptophysin, PSD-95, spinophilin, GluR1 and NMDAR1 mRNA and protein expression

    decreases

    maternal BPA exposure decreased the mRNA and protein expressions of synaptophysin, PSD-95, spinophilin, GluR1 and NMDAR1 in the hippocampus of male offspring on PND 21

    PMID 24820113 · one of two readings recorded this

  • ATP1A2 expression in microarray meta-analysis (log2 fold change)

    increases, p = 0.00000613

    UNC5B | unc-5 Homolog B | −1.4892 | 3.45E–06 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 0.9995 | 6.13E–06

    PMID 25051057 · one of two readings recorded this

  • ESR1 expression in microarray meta-analysis (log2 fold change)

    increases, p = 0.00000274

    PAX6 | paired box 6 | −1.9937 | 1.05E–08 | ESR1 | estrogen receptor 1 | 1.1477 | 2.74E–06

    PMID 25051057 · one of two readings recorded this

  • Number of differentially expressed genes

    (1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)

    PMID 25051057 · one of two readings recorded this

  • Number of differentially expressed genes

    (1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)

    PMID 25051057 · one of two readings recorded this

  • Number of differentially expressed genes

    (1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)

    PMID 25051057 · one of two readings recorded this

  • Number of differentially expressed genes

    (1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)

    PMID 25051057 · one of two readings recorded this

  • Number of differentially expressed genes

    (1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)

    PMID 25051057 · one of two readings recorded this

  • Pax6 expression in cord blood, high vs low BPA group (fold change)

    decreases

    Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively)

    PMID 25051057 · one of two readings recorded this

  • PAX6 expression in microarray meta-analysis (log2 fold change)

    decreases, p = 1.05e-8

    PAX6 | paired box 6 | −1.9937 | 1.05E–08 | ESR1 | estrogen receptor 1 | 1.1477 | 2.74E–06

    PMID 25051057 · one of two readings recorded this

  • Sox2 and Pax6 mRNA expression in human umbilical cord blood by real-time PCR, high vs low cord-blood BPA group (median 16.8 nM, n = 20); plus meta-analysis of three public microarray datasets of human cell models

    decreases, fold change 0.1 (Sox2) and 0.08 (Pax6), high vs low BPA group, n = 20

    Not recorded as a finding: this platform holds no node for the endpoint

    Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively).

    PMID 25051057 · one of two readings recorded this

  • Sox2 and Pax6 mRNA expression in human umbilical cord blood, high vs low BPA group (median 16.8 nM), real-time PCR; plus microarray meta-analysis of differentially expressed genes in human cell models exposed to BPA

    decreases, fold change 0.1 (Sox2) and 0.08 (Pax6), high vs low BPA group

    Not recorded as a finding: this platform holds no node for the endpoint

    Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively).

    PMID 25051057 · one of two readings recorded this

  • Sox2 expression in cord blood, high vs low BPA group (fold change)

    decreases

    Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively)

    PMID 25051057 · one of two readings recorded this

  • SOX2 expression in microarray meta-analysis (log2 fold change)

    decreases, p = 3.22e-10

    SOX2 | SRY (Sex Determining Region Y)-Box 2 | −1.20 | 3.22E–10 | TGFB2 | transforming growth factor, beta 2 | 0.9657 | 5.07E–07

    PMID 25051057 · one of two readings recorded this

  • TGFB2 expression in microarray meta-analysis (log2 fold change)

    increases, p = 5.07e-7

    SOX2 | SRY (Sex Determining Region Y)-Box 2 | −1.20 | 3.22E–10 | TGFB2 | transforming growth factor, beta 2 | 0.9657 | 5.07E–07

    PMID 25051057 · one of two readings recorded this

  • UNC5B expression in microarray meta-analysis (log2 fold change)

    decreases, p = 0.00000345

    UNC5B | unc-5 Homolog B | −1.4892 | 3.45E–06 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 0.9995 | 6.13E–06

    PMID 25051057 · one of two readings recorded this

  • glycaemia, glucose tolerance and cholesterolemia

    increases

    We report a specific impact of BPA exposure on glycaemia, glucose tolerance and cholesterolemia

    PMID 25168180 · one of two readings recorded this

  • hepatic mRNA of cholesterol biosynthesis genes Mvd, Lss, Hmgcr and Sqle

    increases

    RT-qPCR performed on hepatic mRNA from same animals demonstrated an overexpression of key genes involved in cholesterol biosynthesis, namely, Mvd, Lss Hmgcr, and Sqle

    PMID 25168180 · one of two readings recorded this

  • plasma lathosterol to cholesterol ratio (whole body cholesterol de novo synthesis)

    increases

    As shown by the plasma lathosterol to cholesterol ratio, a surrogate marker for cholesterol biosynthesis, whole body cholesterol de novo synthesis was also increased in BPA-exposed animals

    PMID 25168180 · one of two readings recorded this

  • sterol regulatory element-binding protein 2 expression

    increases

    BPA also induced the expression of the sterol regulatory element-binding proteins 2, a master regulator of hepatic cholesterol biosynthesis

    PMID 25168180 · one of two readings recorded this

  • Abnormal glucose (FPG >=100 mg/dL) in children, adjusted OR

    no effect

    Q3: 2.6–4.9 | Q4 vs. Q1: OR = 0.63 (0.22–1.82)

    PMID 26026606 · one of two readings recorded this

  • BMI, correlation with BPA

    increases, p = 0.001

    BMI: r = 0.298 (p < 0.001)

    PMID 26026606 · one of two readings recorded this

  • Body weight, adjusted beta

    increases

    Weight: β = 0.0064 (0.0023–0.0104)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    no effect

    Q4 vs. Q1: OR = 1.71 (0.89–3.26)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.37 (1.08–1.74)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.68 (1.22–2.30)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    no effect

    Pooled 2003/08: OR = 1.065 (0.973–1.166)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    OR = 1.39 (1.21–1.60)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Pooled 2003/06: OR = 1.24 (1.10–1.40)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Pooled 2003/08: OR = 1.08 (1.02–1.16)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Q4 vs. Q1: OR = 3.17 (1.23–8.18)

    PMID 26026606 · one of two readings recorded this

  • Diabetes, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.56 (1.09–2.24)

    PMID 26026606 · one of two readings recorded this

  • Elevated waist circumference, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.59 (1.21–2.09)

    PMID 26026606 · one of two readings recorded this

  • Elevated waist circumference, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.28 (1.03–1.60)

    PMID 26026606 · one of two readings recorded this

  • Fat mass, correlation with BPA

    increases, p = 0.001

    Fat mass: r = 0.35 (p < 0.001)

    PMID 26026606 · one of two readings recorded this

  • High blood pressure, adjusted OR

    no effect

    Weighted model (additionally adjusted for subsample weighting): OR = 1.12 (0.93–1.35)

    PMID 26026606 · one of two readings recorded this

  • Hyperglycemia (FPG >=100 mg/dL), adjusted OR

    no effect

    Q4 vs. Q1: OR = 1.1 (0.6–1.9)

    PMID 26026606 · one of two readings recorded this

  • Incident CAD, adjusted OR

    increases

    OR = 1.11 (1.00–1.23)

    PMID 26026606 · one of two readings recorded this

  • Incident diabetes, adjusted OR

    no effect

    no significant results were found in older women from the NHS study (OR = 0.81, 95 % CI: 0.48–1.38, for Q4 vs. Q1)

    PMID 26026606 · one of two readings recorded this

  • Incident diabetes, adjusted OR

    increases

    a positive association between uBPA and incident diabetes was reported among middle-aged women from the NHSII study (OR = 2.08, 95 % CI: 1.17–3.69, for Q4 vs. Q1)

    PMID 26026606 · one of two readings recorded this

  • Prediabetes, adjusted OR

    increases

    T3 vs. T1: OR = 1.34 (1.03–1.73)

    PMID 26026606 · one of two readings recorded this

  • Prediabetes, adjusted OR

    increases

    T3 vs. T1: OR = 1.65 (1.04–2.80)

    PMID 26026606 · one of two readings recorded this

  • Prediabetes, adjusted OR

    increases

    T3 vs. T1: OR = 1.49 (1.00–2.22)

    PMID 26026606 · one of two readings recorded this

  • Prevalent BMI as continuous, adjusted beta

    increases

    Wang et al. 2012b | Prevalent BMI as continuous (kg/m2) | BPA continuous (log-transformed and corrected for specific gravity) | β = 0.017 (0.002–0.032) | Age, sex

    PMID 26026606 · one of two readings recorded this

  • Prevalent diabetes, pooled OR by uBPA quartile

    increases

    Pooled ORs (95 % CI) were 1.33 (1.10–1.61), 1.18 (0.97–1.44) and 1.47 (1.21–1.80) in the second, third, and fourth uBPA quartiles compared to the first uBPA quartile

    PMID 26026606 · one of two readings recorded this

  • Prevalent diabetes, pooled OR by uBPA quartile

    no effect

    Pooled ORs (95 % CI) were 1.33 (1.10–1.61), 1.18 (0.97–1.44) and 1.47 (1.21–1.80) in the second, third, and fourth uBPA quartiles compared to the first uBPA quartile

    PMID 26026606 · one of two readings recorded this

  • Prevalent diabetes, pooled OR highest vs lowest uBPA

    increases

    Prevalent diabetes | 3 | 1.47 (1.21–1.80) | 0.55 | 0

    PMID 26026606 · one of two readings recorded this

  • Prevalent elevated waist circumference, pooled OR highest vs lowest uBPA

    increases

    Total | 4 | 1.48 (1.25–1.76) | 0.28 | 21

    PMID 26026606 · one of two readings recorded this

  • Prevalent elevated waist circumference, pooled OR highest vs lowest uBPA

    increases

    Adults only | 3 | 1.52 (1.21–1.90) | 0.15 | 47

    PMID 26026606 · one of two readings recorded this

  • Prevalent hypertension, adjusted OR

    no effect

    Q4 vs. Q1: OR = 1.27 (0.85–1.88)

    PMID 26026606 · one of two readings recorded this

  • Prevalent hypertension, adjusted OR

    increases

    T3 vs. T1: OR = 1.50 (1.12–2.00)

    PMID 26026606 · one of two readings recorded this

  • Prevalent hypertension, adjusted OR

    increases

    Q4 vs. Q1: OR = 2.35 (1.33–4.17)

    PMID 26026606 · one of two readings recorded this

  • Prevalent hypertension, pooled OR highest vs lowest uBPA

    increases

    Prevalent hypertension | 2 | 1.41 (1.12–1.79) | 0.50 | 0

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 2.55 (1.65–3.95)

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.76 (1.06–2.94)

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 2.05 (1.38–3.04)

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.69 (1.30–2.20)

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 2.57 (1.72–3.83)

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, adjusted OR

    increases

    Q4 vs. Q1: OR = 1.50 (1.15–1.97)

    PMID 26026606 · one of two readings recorded this

  • prevalent obesity and elevated waist circumference by urinary BPA, pooled OR highest vs lowest category of cross-sectional studies; also prevalent diabetes, overweight and hypertension pooled ORs

    increases

    Not recorded as a finding: this platform holds no node for the endpoint

    Higher BPA exposure was significantly associated with obesity and elevated WC, and no significant heterogeneity between studies was found (Table 5).

    PMID 26026606 · one of two readings recorded this

  • prevalent obesity, elevated waist circumference, overweight, hypertension and prevalent diabetes; pooled OR of highest vs lowest urinary BPA category from cross-sectional studies, random effects (obesity pooled OR 1.67, 95% CI 1.41-1.98 in Table 5)

    increases

    Not recorded as a finding: this platform holds no node for the endpoint

    Higher BPA exposure was significantly associated with obesity and elevated WC, and no significant heterogeneity between studies was found (Table 5).

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, pooled OR highest vs lowest uBPA

    increases

    Total | 3 | 1.67 (1.41–1.98) | 0.44 | 0

    PMID 26026606 · one of two readings recorded this

  • Prevalent obesity, pooled OR highest vs lowest uBPA

    increases

    Adults only | 2 | 1.60 (1.32–1.93) | 0.54 | 0

    PMID 26026606 · one of two readings recorded this

  • Prevalent overweight, adjusted OR

    no effect

    Q4 vs. Q1: OR = 1.31 (0.80–2.14)

    PMID 26026606 · one of two readings recorded this

The whole record — 443 rows